EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling the Potential of Vitamin B 3 -Derived Salts with a Salicylate Anion as Dermal Active Agents for Acne Treatment

Adriana Olejniczak iD, Witold Stachowiak iD, Daniel Ziental iD, Jolanta Długaszewska, Tomasz Rzemieniecki iD, Marcin Wysokowski iD, Teofil Jesionowski iD, Michał Niemczak iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Adriana Olejniczak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, Poznan 60-965, Poland. Hauptthemen laut MEDLINE: Acne Vulgaris, Niacinamide, Molecular Docking Simulation, Anti-Bacterial Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstwo Edukacji i Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study is focused on the utilization of naturally occurring salicylic acid and nicotinamide (vitamin B3) in the development of novel sustainable Active Pharmaceutical Ingredients (APIs) with significant potential for treating acne vulgaris. The study highlights how the chemical structure of the cation significantly influences surface activity, lipophilicity, and solubility in aqueous media. Furthermore, the new ionic forms of APIs, the synthesis of which was assessed with Green Chemistry metrics, exhibited very good antibacterial properties against common pathogens that contribute to the development of acne, resulting in remarkable enhancement of biological activity ranging from 200 to as much as 2000 times when compared to salicylic acid alone. The molecular docking studies also revealed the excellent anti-inflammatory activity of N-alkylnicotinamide salicylates comparable to commonly used drugs (indomethacin, ibuprofen, and acetylsalicylic acid) and were even characterized by better IC50 values than common anti-inflammatory drugs in some cases. The derivative, featuring a decyl substituent in the pyridinium ring of nicotinamide, exhibited efficacy against Cutibacterium acnes while displaying favorable water solubility and improved wettability on hydrophobic surfaces, marking it as particularly promising. To investigate the impact of the APIs on the biosphere, the EC50 parameter was determined against a model representative of crustaceans─Artemia franciscana. The majority of compounds (with the exception of the salt containing the dodecyl substituent) could be classified as "Relatively Harmless" or "Practically Nontoxic", indicating their potential low environmental impact, which is essential in the context of modern drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisNiacinamideMolecular Docking SimulationAnti-Bacterial AgentsHumansSolubilitySalicylatesMicrobial Sensitivity TestsSaltsPropionibacteriaceaeAnti-Inflammatory AgentsAnionsSalicylic Acid

Stichwörter der Autor:innen

APIacne vulgarisactive pharmaceutical ingredientsantimicrobial activitynicotinamidesalicylic acid

Substanzen

NiacinamideAnti-Bacterial AgentsSalicylatesSaltsAnti-Inflammatory AgentsAnionsSalicylic Acid

Autor:innen und Institutionen

  • Faculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, Poznan 60-965, Poland.
  • Chair and Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, Poznan 60-806, Poland.
  • Chair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Rokietnicka 3, Poznan 60-806, Poland.

ORCID-Profile: Adriana Olejniczak, Witold Stachowiak, Daniel Ziental, Tomasz Rzemieniecki, Marcin Wysokowski, Teofil Jesionowski, Michał Niemczak

Förderung

  • Ministerstwo Edukacji i Nauki

Zitieren

APA

Olejniczak, A., Stachowiak, W., Ziental, D., Długaszewska, J., Rzemieniecki, T., Wysokowski, M., Jesionowski, T., & Niemczak, M. (2024). Unraveling the Potential of Vitamin B 3 -Derived Salts with a Salicylate Anion as Dermal Active Agents for Acne Treatment. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00543

Vancouver

Olejniczak A, Stachowiak W, Ziental D, Długaszewska J, Rzemieniecki T, Wysokowski M, et al. Unraveling the Potential of Vitamin B 3 -Derived Salts with a Salicylate Anion as Dermal Active Agents for Acne Treatment. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00543

BibTeX
@article{Olejniczak2024,
  author = {Olejniczak, Adriana and Stachowiak, Witold and Ziental, Daniel and Długaszewska, Jolanta and Rzemieniecki, Tomasz and Wysokowski, Marcin and Jesionowski, Teofil and Niemczak, Michał},
  title = {Unraveling the Potential of Vitamin B 3 -Derived Salts with a Salicylate Anion as Dermal Active Agents for Acne Treatment},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00543}
}
Kostenlos starten →